Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topotecan Combinations in Recurrent Ovarian Cancer
NCT00312988Phase 3Completed
- Sponsor
- NOGGO
- Start
- Jan 2000
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of etoposide, gemcitabine in ovarian cancer, sponsored by NOGGO. Started Jan 2000; status: completed.
02
Drugs
etoposidegemcitabine
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on NCT00312988.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00312988.